# Clinical Evaluation of Flortaucipir F 18

> **NCT02278367** · PHASE2 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 179 (actual)

## Conditions studied

- Alzheimer's Disease
- Traumatic Brain Injury
- Depression

## Interventions

- **DRUG:** Flortaucipir F18
- **PROCEDURE:** Brain PET scan

## Key facts

- **NCT ID:** NCT02278367
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2019-06-26
- **Final completion:** 2019-06-26
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2020-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02278367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02278367, "Clinical Evaluation of Flortaucipir F 18". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02278367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*